Bill

Bill > A2653


NJ A2653

NJ A2653
Prohibits using cadaveric fetal tissue obtained from elective abortion procedure for research purposes and using any cadaveric fetal tissue to research cosmetic treatments.


summary

Introduced
01/09/2024
In Committee
01/09/2024
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

Under current law, women are given the opportunity to voluntarily donate unused embryos and cadaveric fetal tissue for research purposes following a course of fertility treatments, a miscarriage, or an abortion. This bill prohibits the use of cadaveric fetal tissue obtained from an elective abortion procedure for any research purposes, and prohibits the use of any cadaveric fetal tissue to research cosmetic treatments. The bill will not prohibit the use of cadaveric fetal tissue obtained following a miscarriage or stillbirth for other research purposes, will not affect the prohibition against purchasing or selling embryonic or cadaveric fetal tissue, which is currently a crime under both State and federal law, and will not prohibit genetic or other testing of fetal tissue, at the parent's request, for the purposes of determining the health or condition of the fetus or the parents. A physician or other health care professional treating a patient for infertility is required to provide the patient with timely, relevant, and appropriate information sufficient to allow the patient to make an informed and voluntary choice regarding the disposition of any embryos remaining following treatment. This bill requires that the patient provide written acknowledgement that this information was provided, and that the written acknowledgement be included in the patient's medical record.

AI Summary

This bill prohibits the use of cadaveric fetal tissue obtained from elective abortion procedures for any research purposes, and prohibits the use of any cadaveric fetal tissue to research cosmetic treatments. However, the bill does not prohibit the use of cadaveric fetal tissue obtained following a miscarriage or stillbirth for other research purposes. It also requires healthcare providers treating patients for infertility to provide them with information to make an informed and voluntary choice regarding the disposition of any remaining embryos, and to include written acknowledgement of this in the patient's medical record.

Committee Categories

Health and Social Services

Sponsors (6)

Last Action

Introduced, Referred to Assembly Health Committee (on 01/09/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...